Tirzepatide vs Semaglutide: Which GLP‑1 Is Right For You?

You’ve seen the headlines. Or a friend dropped 40 pounds on Ozempic®. Maybe your coworker just started Mounjaro®. These meds aren’t fringe anymore, they’re at Walgreens, on TikTok, and maybe in your group chat.

But what social media lacks is an explanation of the different types of GLP-1 available.

This guide compares the two most popular GLP-1s, semaglutide and tirzepatide. We’ll cover side effects, results, and costs to help you decide which prescription might work best for your own stubborn weight loss.

How Tirzepatide and Semaglutide Help You Lose Weight

GLP-1 medications like semaglutide and tirzepatide are FDA approved for adults with a BMI of 30 or more. They’re also approved for people with a BMI of 27 and at least one weight-related condition, like high blood pressure, high cholesterol, polycystic ovary syndrome (PCOS), or prediabetes.

These medications don’t just make you “less hungry,” they change how your body processes food, stores fat, and regulates energy.

Before prescribing, providers will check for any red flags, like a personal or family history of medullary thyroid cancer or gastrointestinal conditions like gastroparesis. But for a lot of people, these meds are not just appropriate, they’re overdue.

How Tirzepatide Works

Tirzepatide works by tapping into two key gut hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both hormones help you say no to excess calories by slowing how quickly food moves through your stomach and telling your brain you’re full.

They also help your body respond better to insulin, the hormone that helps move sugar from your blood into your muscles for fuel. They help signal fat cells to release stored energy instead of holding on tight.

The effect is that the bagel you used to crave at 10 a.m. might not even cross your mind, and your blood sugar stays on a much smoother ride.

In the SURMOUNT-1 clinical trial, patients taking the highest dose (15 mg) of tirzepatide lost about 21% of their body weight over 72 weeks.^[1] That’s roughly 50 pounds for someone starting at 240, and nearly 57% of participants hit that 20% loss mark.

How Semaglutide Works 

Semaglutide focuses solely on the GLP-1 pathway. After you eat, it helps slow digestion, meaning your stomach empties more gradually, so you feel full longer. It also tells your brain you’ve had enough, reducing the urge to snack or graze.

The STEP 1 trial found that people taking 2.4 mg of semaglutide weekly lost an average of 15% of their body weight over about 16 months.^[2] That’s typically 30 to 35 pounds, and over half of patients lost at least 15%.

In daily life, many users report naturally gravitating toward smaller portions and saying no to late-night cravings, without white-knuckling their way through it.

Can You Use Tirzepatide or Semaglutide Without Diabetes?

It’s true that GLP-1s began as a type 2 diabetes treatment, among other conditions besides weight loss. But you can absolutely use tirzepatide or semaglutide without being diagnosed with type 2 diabetes. 

Both medications were tested in large clinical trials with thousands of people who didn’t have diabetes. And the results weren’t modest; they were headline-worthy. People lost significant weight even without blood sugar issues.

When GLP-1s became popular for weight loss, the market saw a shortage of them, which is why the FDA allowed compounding pharmacies to begin formulating non-branded, compounded versions of them. Now that the shortage is over, though, the FDA has withdrawn that approval. You can still find compounded versions, but they come with some risk. If that concerns you, stick to branded versions.

Wegovy® and Zepbound® are now fully FDA approved for chronic weight management, regardless of diabetes status, as long as you meet the BMI or health condition criteria.

However, Ozempic (another form of semaglutide) and Mounjaro (tirzepatide) are only FDA approved for type 2 diabetes, not weight loss. Still, many doctors prescribe them “off-label” to help patients manage their weight because the active ingredient is the same as in Wegovy and Zepbound, just at a different dose.

What to Expect When Taking Tirzepatide and Semaglutide

While both tirzepatide and semaglutide are effective weight-loss solutions, their effects have some variations:

• Semaglutide helps you feel full faster and longer, leading to fewer calories without the gnawing hunger. 

• Tirzepatide may take it a step further, leveraging combined GIP and GLP-1 actions to curb appetite, boost energy expenditure, and drive greater weight loss.

• Some patients describe better energy stability and fewer sugar crashes on tirzepatide. That could be because GIP may help improve insulin sensitivity more alongside GLP-1, a metabolic edge semaglutide doesn’t fully match.

A recent study compared semaglutide and tirzepatide for weight loss and found that tirzepatide resulted in 2.4% more weight loss at 3 months, 4.3% more at 6 months, and 6.9% more at 12 months. Both medications had similar gastrointestinal side effects.^[3] 

Additionally, a study of 2,405 patients found an average weight loss of 2.2% after 72 weeks on GLP-1 medications. While not as dramatic as trial results, this shift can still be significant for individuals struggling with weight. About one-third of patients achieved a weight loss of 5% or more.^[4]

In practical terms? People on Reddit and patient forums often report clothes fitting looser within the first 2–3 months and seeing consistent progress after each dose increase. It’s not uncommon to hear “this is the first thing that’s worked for me.”

Keeping the Weight Off Long Term 

These medicines are not magic; they’re ongoing metabolic support. Still, you have to take them diligently if you want to see results.

One study found that after stopping tirzepatide, nearly 7 out of 10 users regained more than 5% of the weight they’d lost within a year, moving closer to their original weight.^[5] Semaglutide shows a similar pattern: Stop the injections, and weight often creeps back up.

But that’s not the only thing that helps keep the weight off. Think of these meds as scaffolding: they support your weight loss but don’t build the whole structure.

People who see the strongest results usually pair their injections with simple changes to eating, movement, and sleep.

Tirzepatide users often describe a “whoosh” of weight loss after each dose increase, one to two pounds a week isn’t uncommon. But plateaus happen. What breaks them? Consistency. A steady dose. Solid sleep. Less stress. Staying connected to a provider who can monitor your dose and keep your GLP-1 working for you.

Treatment and Dosing With Tirzepatide and Semaglutide

Dosing begins low (0.25 mg with semaglutide or 2.5 mg with tirzepatide) and goes up gradually, this is called titration. Your provider will adjust every four weeks until you reach your optimal dose, semaglutide around 2.4 mg, tirzepatide around 5, 10, or 15 mg.

Shortcuts or skipping steps can trigger nausea, cramps, or dizziness. Patience pays off.

Both drugs use weekly injection pens. You might hear about oral semaglutide (Rybelsus®), but that’s only approved for diabetes, and the dose isn’t typically high enough for weight loss. TikTok might mention GLP-1 “drops” or “oral sprays,” but there’s little evidence they work. The pens are the real deal.

The injection takes under 10 seconds. Pick a day (most people go with Sunday or Monday), wipe your skin, click the pen, and you’re done.

Some pharmacies will give you a vial and separate syringes, meaning you’ll have to measure out the appropriate dosage yourself, but most people prefer prefilled injection pens. They’re far easier to use. 

Side Effects of Tirzepatide and Semaglutide

These medications aren’t silent passengers—they come with a few bumps along the way, especially during the first few weeks or when your dose increases:

• nausea: a rolling, unsettled stomach that may show up right after meals or linger all day
• vomiting: especially after overeating or with certain foods
• bloating: a tight, uncomfortable feeling in your midsection
• gas: often unexpected and frequent
• constipation: hard stools or fewer bowel movements than usual
• diarrhea: loose or urgent stools, sometimes alternating with constipation
• loss of appetite: you forget to eat, or food just doesn’t appeal anymore
• fatigue: a general sense of low energy or sluggishness, especially early on
• burping or acid reflux: a burning sensation or repeated belching after meals
• mild headache: usually short-lived and manageable with rest or hydration
• injection-site soreness, redness, swelling, or itching: typically mild and short-lived 

These symptoms often peak during dose escalation and tend to ease as your body adjusts. 

Call your provider right away if you experience any of the following symptoms, which may indicate a more serious reaction:

• persistent vomiting
• severe abdominal pain
• signs of dehydration (dry mouth, dizziness, dark urine)

These can signal something more serious, like pancreatitis or gallbladder irritation—rare but real risks.

Comparing the two, tirzepatide sometimes brings more intense GI effects, especially at higher doses. 

That’s partly because it acts on two gut hormone pathways instead of one. Some people tolerate semaglutide better, and others do fine with tirzepatide from the start.

Serious but rare issues like pancreatitis or gallbladder disease can occur in either case. That’s why medical oversight and honest conversations matter.

How Much Do These Medications Cost?

Here’s a breakdown of the most common GLP-1 brands, what they contain, and what you might expect to pay, including lower-cost compounded alternatives:

• Wegovy (semaglutide)
  • FDA approved for weight loss
  • Estimated retail price: $1,350/month

• Ozempic (semaglutide)
  • FDA approved for type 2 diabetes; prescribed off-label for weight loss
  • Estimated retail price: $950–$1,200/month

• Zepbound (tirzepatide)
  • FDA approved for weight loss
  • Estimated retail price: $1,080–$1,200/month

• Mounjaro (tirzepatide)
  • FDA approved for type 2 diabetes; sometimes used off-label for weight loss
  • Estimated retail price: $1,000–$1,200/month

• Rybelsus® (semaglutide)
  • Oral tablet approved for treatment of type 2 diabetes; prescribed off-label for weight loss
  • Estimated retail price: $800–$1300/month

• Compounded semaglutide 
  • Not FDA approved
  • Estimated retail price: $200–$600, cheaper prices with subscriptions service available

👉 Find a semaglutide compounding pharmacy.

• Compounded tirzepatide
  • Not FDA approved
  • Estimated retail price: $300–$600, cheaper prices with subscriptions service available

👉 Find a tirzepatide compounding pharmacy.

Insurance coverage is improving in some employer-linked plans, but large gaps remain. Manufacturer coupons, HSA/FSA options, and participating pharmacies can drop costs to under $100 per month for some insured patients.

Many cheaper compounded versions were circulating, until FDA crackdowns began this spring. The shortage lifted, but regulators are limiting compounding options due to quality concerns. That means the risk-return calculation has shifted: cheaper isn’t always safe.

👉 Turning to an online weight-loss clinic might actually cut costs.

What Real Patients Say About These Drugs

From r/Semaglutide, one user reported mild headache:

Another shared dramatic results:

On Tirzepatide forums, one user reported eventual setbacks:

Another described the common pattern of early loss followed by plateaus:

These stories show steadiness with full-dose use, but also a mix of relief, frustration, and surprise along the way. Lifestyle changes, including exercise and nutrition, and key to maintaining results from GLP-1s like tirzepatide and semaglutide. Which GLP-1 your doctor prescribes can also affect results.

How to Choose the Right GLP-1 for You

Choosing between GLP-1 medications like tirzepatide and semaglutide depends on individual factors, so the best GLP-1 for your friend may not be the best for you. 

Consider tirzepatide for stronger metabolic impact, especially with insulin resistance or type 2 diabetes, because it targets two hormones (GLP-1 and GIP). 

Semaglutide might be better for those concerned about cost, side effects, or underlying metabolic conditions, given its longer real-world data and gentler side effect profile.

Questions to Ask Your Doctor Before Starting

Here are some key questions to ask your doctor before starting medication:

• What’s better for my physiology and goals, semaglutide or tirzepatide?
• What’s your approach to increasing the dose and handling side effects?
• What lab tests will you run before starting?
• What’s the plan if I don’t see progress?
• Do you incorporate lifestyle changes like sleep, stress, and exercise into your treatment plan?

Trust your instincts, if the clinic feels rushed or vague, it might be a red flag. But also take the time to find one that matches your needs. If you don’t want extra guidance, find a clinic with a more hands-off approach.

Your Next Steps

Neither medication is magic. Both require commitment, to dosing, check-ups, and lifestyle habits. Expect early discomfort, financial commitment, and a shift in thinking about weight as a chronic condition rather than a temporary problem.

If you’ve tried every diet trick without lasting success, this may be the tool that finally works in your favor, not against inbuilt quirks of metabolism.

Ready to take the next step? 

👉 Check out the best online GLP‑1 programs to find the right fit.

FAQs

Do I have to take injections forever?

No, you don’t necessarily need to take injections forever, but it depends on your body and goals. These medications treat obesity as a chronic condition, much like high blood pressure or diabetes. That means they’re designed for long-term use. While some individuals may be able to switch to a lower maintenance dose after achieving their weight loss goals, completely stopping treatment typically leads to a reversal of the progress made.

Can I stop once I hit my goal weight?

Yes, you can stop once you hit your goal but it’s risky. Stopping medication once you reach your goal weight might sound appealing, but it often results in weight regain. To maintain sustained results, some switch to a lower dose after 12–18 months, but only under a doctor’s guidance. This allows your healthcare provider to monitor your progress and adjust your treatment plan as needed.

What’s the difference between compounded versions and name brands?

The difference between compounded versions of these medications and name brands comes down to regulation and safety. Compounded meds are not inspected by the FDA, and that lack of quality control means they pose some level of risk, including incorrect dosing, contamination, and the use of expired ingredients. Name brands, on the other hand, adhere to strict quality standards.

Can I use these while doing keto or intermittent fasting?

You can use these medications with other diets like keto or intermittent fasting. To ensure safe and effective use, it’s essential to maintain adequate protein intake, fiber consumption, and hydration. If you experience any changes in energy levels or digestion, consult your doctor to adjust your treatment plan accordingly.

References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 ↩︎
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 ↩︎
3. Rodriguez, P. J., Cartwright, B. M. G., Gratzl, S., Brar, R., Baker, C., Gluckman, T. J., & Stucky, N. L. (2024). Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity. JAMA Internal Medicine, 184(9), 1056–1064. https://doi.org/10.1001/jamainternmed.2024.2525 ↩︎
4. White, G. E., Shu, I., Rometo, D., Arnold, J., Korytkowski, M., & Luo, J. (2023). Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study. Obesity, 31(2), 537–544. https://doi.org/10.1002/oby.23622 ↩︎
5. Quarenghi, M., Capelli, S., Galligani, G., Giana, A., Preatoni, G., & Turri Quarenghi, R. (2025). Weight regain after liraglutide, semaglutide or tirzepatide interruption: A narrative review of randomized studies. Journal of Clinical Medicine, 14(11), 3791. https://doi.org/10.3390/jcm14113791 ↩︎